Randolph Fish
Primary Podiatric Medicine · Tacoma, WANPI 1063493559
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,571 of the $5,583 with a category attached, or 64.0%. Musculoskeletal Transplant Foundation Inc. accounts for 61.4% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $2,004 and has fallen 84.4% since, to $312 in 2025.
Across 40 payments — averaging $139.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$3K
- Smith+Nephew$730
- Osiris Therapeutics Inc.$302
- Paratek Pharmaceuticals, Inc.$214
- Stryker$138
- Paragon 28, Inc.$108
- plus $662 from 10 others
What the payments were for
- Travel & lodging$2,01236%
- Food & beverage$3,57164%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 8 | $3,429 |
| Smith+Nephew | 11 | $730 |
| Osiris Therapeutics Inc. | 4 | $302 |
| Paratek Pharmaceuticals, Inc. | 2 | $214 |
| Stryker | 1 | $138 |
| Paragon 28, Inc. | 3 | $108 |
| Bone Support Inc. | 1 | $106 |
| Fusion Orthopedics USA, LLC | 1 | $100 |
| Linvatec Corporation | 1 | $75 |
| Amgen | 1 | $69 |
| AbbVie | 1 | $68 |
| Organogenesis Inc. | 1 | $67 |
| Nevro Corp. | 1 | $63 |
| Zimvie Inc. | 1 | $63 |
| Mimedx Group, Inc. | 2 | $38 |
| Reprise Biomedical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$138
- Stravix$128
- NUZYRA$125
- Grafix PL PRIME$118
- CERAMENTBONE VOID FILLER$106
- CERAMENT G$106
How this compares
Too few primary podiatric medicine providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 11 | $295 |
| Levofloxacin | 12 | $34 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Tacoma
- Nathan HansenMill Creek$4K
- Randall FisherEverett$3K
- Timothy GracePuyallup$382
- Hugh GoreyEdgewood$345
- Karen SkidmorePoulsbo$321
- William TronvigAberdeen$294
- Julia OverstreetBellevue$234
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.